MCKESSON CORP (MCK) Latest Filing Signal

Latest Filing: 10-Q  |  Filed Feb 4, 2026

Cross-checked across multiple AI analysts and grounded in the latest SEC filing.

powered by: earningsVibe.ai

Question:
What is the latest filing signal for MCKESSON CORP?
Answer:
Based on earningsVibe SuperAnalyst™ synthesis of the latest 10-Q, MCKESSON CORP's filing signal turned positive.
earningsVibe SuperAnalyst™ Verdict: TURNED POSITIVE

Signal Performance — Stock Price Since Filing

30-Day Change
+11.93%
from filing date
60-Day Change
+4.32%
from filing date

Underlying analyst views from Perplexity, Gemini, Claude, and ChatGPT

PERPLEXITY
Continuing Positive
GEMINI
Turned Positive
CLAUDE
Turned Positive
CHATGPT
Continuing Positive

Unlock the Full Filing Analysis

See full earningsSig™ and risksSig™ analysis across 5,000+ companies

Get Started Free →

No credit card required

Question:
What does MCKESSON CORP actually do?
Answer:
McKesson Corporation is a diversified healthcare services leader that partners with biopharma companies, care providers, pharmacies, manufacturers, and governments to improve healthcare accessibility and affordability. The company operates through four distinct segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. Its U.S. Pharmaceutical segment is a major distributor of pharmaceuticals and provides practice management and technology solutions to specialty practices. The RxTS segment focuses on medication access, affordability, and adherence through technology services and logistics. The Medical-Surgical Solutions segment distributes medical-surgical supplies, and the International segment operates in Canada and Norway. McKesson leverages technology and data analytics to enhance efficiency and patient outcomes across its operations.
Question:
What are MCKESSON CORP's revenue drivers?
Answer:
Revenue is primarily driven by the distribution of pharmaceutical drugs and medical-surgical supplies across its various segments. Growth is also supported by technology services within the RxTS segment and specialty health services in its international operations.

Cut through noisy SEC filings to find the signal faster

Source-grounded filing intelligence with one-click links back to the filing, so you can move faster and verify everything at the source.

Get Started Free →

No credit card required